Kcne2 deletion causes early-onset nonalcoholic fatty liver disease via iron deficiency anemia

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lee, Soo Min ^a   Nguyen, Dara ^a   Anand, Marie ^a   Kant, Ritu ^a   Kohncke, Clemens ^b   Lisewski, Ulrike ^b   Roepke, Torsten K ^b,c   Hu, Zhaoyang ^d   Abbott, Geoffrey W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; KCNE2 PROTEIN, MOUSE; TRANSCRIPTOME; TRIACYLGLYCEROL; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL; BLOOD; C57BL MOUSE; COMPLICATION; DEFICIENCY; FEMALE; GENE DELETION; GENE REGULATORY NETWORK; GENETICS; GERMLINE MUTATION; IRON DEFICIENCY ANEMIA; KNOCKOUT MOUSE; LIPID DIET; LIVER; MALE; METABOLISM; MOUSE; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

ANEMIA, IRON-DEFICIENCY; ANIMALS; C-REACTIVE PROTEIN; DIET, HIGH-FAT; FEMALE; GENE REGULATORY NETWORKS; GERM-LINE MUTATION; HOMOCYSTEINE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NON-ALCOHOLIC FATTY LIVER DISEASE; POTASSIUM CHANNELS, VOLTAGE-GATED; SEQUENCE DELETION; TRANSCRIPTOME; TRIGLYCERIDES;

EID: 84962568056     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23118     Document Type: Article

References (37)

1. Anstee, Q. M., Day, C. P. The genetics of NAFLD. Nat Rev Gastroenterol Hepatol 10, 645-655 (2013).
2. Clark, J. M., Diehl, A. M. Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep 2, 210-215 (2002).
3. Dongiovanni, P., Valenti, L. Genetics of nonalcoholic fatty liver disease. Metabolism (2015).
4. He, S. et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 285, 6706-6715 (2010).
5. Li, J. Z. et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J Clin Invest 122, 4130-4144 (2012).
6. Yang, Z. et al. Genetic variation in the GCKR gene is associated with non-alcoholic fatty liver disease in Chinese people. Mol Biol Rep 38, 1145-1150 (2011).
7. Song, J. et al. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J 19, 1266-1271 (2005).
8. Al-Serri, A. et al. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. J Hepatol 56, 448-454 (2012).
9. Watanabe, K., Ohnishi, S., Manabe, I., Nagai, R., Kadowaki, T. KLF6 in nonalcoholic fatty liver disease: role of fibrogenesis and carcinogenesis. Gastroenterology 135, 309-312 (2008).
10. Yoneda, M. et al. Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease. Liver Int 29, 1078-1085 (2009).
11. Ahmed, U., Latham, P. S., Oates, P. S. Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis. World J Gastroenterol 18, 4651-4658 (2012).
12. Hu, Z. et al. Kcne2 deletion creates a multisystem syndrome predisposing to sudden cardiac death. Circ Cardiovasc Genet 7, 33-42 (2014).
13. Abbott, G. W. et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97, 175-187 (1999).
14. Sabater-Lleal, M. et al. Common genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery disease. PLoS One 9, e104082 (2014).
15. Lee, S. M., Nguyen, D., Hu, Z., Abbott, G. W. Kcne2 deletion promotes atherosclerosis and diet-dependent sudden death. J Mol Cell Cardiol (2015).
16. McCrossan, Z. A., Abbott, G. W. The MinK-related peptides. Neuropharmacology 47, 787-821 (2004).
17. Abbott, G. W. The KCNE2 K(+ ) channel regulatory subunit: Ubiquitous influence, complex pathobiology. Gene 569, 162-172 (2015).
18. Roepke, T. K. et al. KCNE2 forms potassium channels with KCNA3 and KCNQ1 in the choroid plexus epithelium. FASEB J 25, 4264-4273 (2011).
19. Roepke, T. K. et al. Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis. Nat Med 15, 1186-1194 (2009).
20. Roepke, T. K. et al. Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K, slow1) and I(to, f). FASEB J 22, 3648-3660 (2008).
21. McCrossan, Z. A., Roepke, T. K., Lewis, A., Panaghie, G., Abbott, G. W. Regulation of the Kv2.1 potassium channel by MinK and MiRP1. J Membr Biol 228, 1-14 (2009).
22. Tinel, N., Diochot, S., Borsotto, M., Lazdunski, M., Barhanin, J. KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel. EMBO J 19, 6326-6330 (2000).
23. Abbott, G. W. et al. KCNQ1, KCNE2, and Na+-Coupled Solute Transporters Form Reciprocally Regulating Complexes That Affect Neuronal Excitability. Sci Signal 7, ra22 (2014).
24. Roepke, T. K. et al. The KCNE2 potassium channel ancillary subunit is essential for gastric acid secretion. J Biol Chem 281, 23740-23747 (2006).
25. Lee, M. P. et al. Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. J Clin Invest 106, 1447-1455 (2000).
26. Roepke, T. K. et al. Genetic dissection reveals unexpected influence of beta subunits on KCNQ1 K+ channel polarized trafficking in vivo. FASEB J 25, 727-736 (2011).
27. Roepke, T. K. et al. Targeted deletion of Kcne2 causes gastritis cystica profunda and gastric neoplasia. PLoS One 5, e11451 (2010).
28. Mutel, E. et al. Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas. J Hepatol 54, 529-537 (2011).
29. Choe, Y. G. et al. Apolipoprotein B/AI ratio is independently associated with non-alcoholic fatty liver disease in nondiabetic subjects. J Gastroenterol Hepatol 28, 678-683 (2013).
30. Salsbury, G. et al. Disruption of the potassium channel regulatory subunit KCNE2 causes iron-deficient anemia. Exp Hematol 42, 1053-1058 e1 (2014).
31. Sherman, A. R., Guthrie, H. A., Wolinsky, I., Zulak, I. M. Iron deficiency hyperlipidemia in 18-day-old rat pups: effects of milk lipids, lipoprotein lipase, and triglyceride synthesis. J Nutr 108, 152-162 (1978).
32. Purtell, K. et al. The KCNQ1-KCNE2 K+ channel is required for adequate thyroid I-uptake. FASEB J (2012).
33. Chung, G. E. et al. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J Hepatol 57, 150-156 (2012).
34. Targher, G., Day, C. P., Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363, 1341-1350 (2010).
35. Dogru, T., Genc, H., Bagci, S. C reactive protein levels in non-alcoholic fatty liver disease. J Hepatol 56, 507-508; author reply 508-10 (2012).
36. Malinow, M. R. Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis. Circulation 81, 2004-2006 (1990).
37. Namekata, K. et al. Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. J Biol Chem 279, 52961-52969 (2004).